เลเวแทม (500 มิลลิกรัม)
LEVETAM (500 MG)
activeLast updated: 2026-07-29
Product & certifications 1
- FDA 1A15012/64(NG)drugคงอยู่
ตัวยาสำคัญ
- LEVETIRACETAM500.000 milligram
- ประเภทควบคุม
- ยาอันตราย
- ข้อบ่งใช้
- LEVETAM is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy. LEVETAM is indicated as adjunctive therapy • in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents, children and infants from 1 month of age with epilepsy. • in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. • in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.
- รหัส ATC
- N03AX14 (levetiracetam)
ข้อมูลตามที่ขึ้นทะเบียนกับ อย. — ไม่ใช่คำแนะนำการใช้ยา ปรึกษาเภสัชกรหรือแพทย์ก่อนใช้เสมอ
- Category
- ยาสำเร็จรูป
- Trade name
- —
- Company / Manufacturer
- องค์การเภสัชกรรมดำเนินกิจการ
- Juristic registration number
- 0994000165315
- Producer's other permits
- See all permits held by this company →
A matching registration number confirms the registration exists — it does not verify that the physical item you hold is genuine. Always compare the product and manufacturer names on the label.
Last updated: 2026-07-29 · Data aggregated from official government databases: NBTC · FDA · TISI · DBD · Dept. of Tourism · ACFSReport incorrect data